Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
02/26/14 | 4 | Rhodes John B |
![]() ![]() |
2 | |
02/26/14 | 4 | Daugherty Bruce |
![]() ![]() |
2 | |
02/26/14 | 4 | Lederman Seth |
![]() ![]() |
2 | |
02/26/14 | 4 | Saks Samuel R |
![]() ![]() |
2 | |
02/14/14 | 8-K | Current report filing |
![]() ![]() |
28 | |
02/14/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
11 | |
02/13/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
7 | |
02/10/14 | 8-K | Current report filing |
![]() ![]() |
30 | |
02/04/14 | 8-K | Current report filing |
![]() ![]() |
4 | |
01/30/14 | 8-K | Current report filing |
![]() ![]() |
3 |